Ramipril and Sacubitril and valsartan interaction

Ramipril and Sacubitril and valsartan: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Ramipril label · effective 2025-07-10

Major

Ramipril capsules are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril).

Contraindicationsby drug classView label on DailyMed
Major

Do not administer ramipril within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor [see Warnings and Precautions (5.1) ] .

Contraindicationsby drug classView label on DailyMed
Major

Ramipril Capsules are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril).

Contraindicationsby drug classView label on DailyMed
Major

Do not administer ramipril capsules within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (4).

Contraindicationsby drug classView label on DailyMed
Moderate

Patients taking concomitant mammalian target of rapamycin (mTOR) inhibitor (e.g. temsirolimus) therapy or a neprilysin inhibitor may be at increased risk for angioedema [see Drug Interactions (7.7) ].

Warnings and precautionsby drug classView label on DailyMed

From the Sacubitril and valsartan (ENTRESTO) label · effective 2026-07-06

Major

ENTRESTO is contraindicated: in patients with hypersensitivity to any component in patients with a history of angioedema related to previous ACE inhibitor or ARB therapy [see Warnings and Precautions (5.2)] with concomitant use of ACE inhibitors.

Contraindicationsby drug classView label on DailyMed
Major

Do not administer within 36 hours of switching from or to an ACE inhibitor [see Drug Interactions (7.1)] with concomitant use of aliskiren in patients with diabetes [see Drug Interactions (7.1)] Hypersensitivity to any component.

Contraindicationsby drug classView label on DailyMed
Major

Concomitant use with ACE inhibitors.

Contraindicationsby drug classView label on DailyMed
Major

ENTRESTO must not be used in patients with a known history of angioedema related to previous ACE inhibitor or ARB therapy [see Contraindications (4)] .

Warnings and precautionsby drug classView label on DailyMed
Major

Dual Blockade of the Renin-Angiotensin-Aldosterone System Concomitant use of ENTRESTO with an ACE inhibitor is contraindicated because of the increased risk of angioedema [see Contraindications (4)] .

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.